Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vestibular phenotype-genotype correlation in a cohort of 90 patients with Usher syndrome. | Clin Genet | 2021 | 33089500 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals pathogenic variants in MYO3A, MYO15A and COL9A3 and differential frequencies in ancestral alleles in hearing impairment genes among individuals from Cameroon. | Hum Mol Genet | 2021 | 33078831 | PubTator, text mining | PubMed |
| Autosomal Recessive Bestrophinopathy: Clinical Features, Natural History, and Genetic Findings in Preparation for Clinical Trials. | Ophthalmology | 2021 | 33039401 | PubTator, text mining | PubMed |
| 3D engineering for optic neuropathy treatment. | Drug Discov Today | 2021 | 33038525 | PubTator, text mining | PubMed |
| Optical coherence tomography angiography findings in patients undergoing transcorneal electrical stimulation for treating retinitis pigmentosa. | Graefes Arch Clin Exp Ophthalmol | 2021 | 33037922 | PubTator, text mining | PubMed |
| Genome-Editing Strategies for Treating Human Retinal Degenerations. | Hum Gene Ther | 2021 | 32993386 | PubTator, text mining | PubMed |
| Visual hallucinations and sight loss in children and young adults: a retrospective case series of Charles Bonnet syndrome. | Br J Ophthalmol | 2021 | 32933935 | PubTator, text mining | PubMed |
| A novel statistical method for interpreting the pathogenicity of rare variants. | Genet Med | 2021 | 32884132 | PubTator, text mining | PubMed |
| Restoring Color Perception to the Blind: An Electrical Stimulation Strategy of Retina in Patients with End-stage Retinitis Pigmentosa. | Ophthalmology | 2021 | 32858064 | PubTator, text mining | PubMed |
| Sector Retinitis Pigmentosa: Extending the Molecular Genetics Basis and Elucidating the Natural History. | Am J Ophthalmol | 2021 | 32795431 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of Patients With Posterior Segment Uveitis. | Am J Ophthalmol | 2021 | 32707200 | PubTator, text mining | PubMed |
| USH2A variants in Chinese patients with Usher syndrome type II and non-syndromic retinitis pigmentosa. | Br J Ophthalmol | 2021 | 32675063 | PubTator, text mining | PubMed |
| Fatal attraction: The roles of ribosomal proteins in the viral life cycle. | Wiley Interdiscip Rev RNA | 2021 | 32657002 | PubTator, text mining | PubMed |
| Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions. | Br J Ophthalmol | 2021 | 32269060 | PubTator, text mining | PubMed |
| Prevalence and genetic-phenotypic characteristics of patients with USH2A mutations in a large cohort of Chinese patients with inherited retinal disease. | Br J Ophthalmol | 2021 | 32188678 | PubTator, text mining | PubMed |
| Vestibular status in partial deafness. | Braz J Otorhinolaryngol | 2021 | 31874831 | PubTator, text mining | PubMed |
| Variant Profiling of a Large Cohort of 138 Chinese Families With Autosomal Dominant Retinitis Pigmentosa. | Front Cell Dev Biol | 2020 | 33598457 | PubTator, text mining | PubMed |
| Sequence variation, common tissue expression patterns and learning models: a genome-wide survey of vertebrate ribosomal proteins. | NAR Genom Bioinform | 2020 | 33575632 | PubTator, text mining | PubMed |
| Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors. | Front Oncol | 2020 | 33409155 | PubTator, text mining | PubMed |
| Implication of the Identification of an Earlier Pseudorabies Virus (PRV) Strain HLJ-2013 to the Evolution of Chinese PRVs. | Front Microbiol | 2020 | 33384679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=57